- To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a first-line metastatic setting.
- To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a second-line metastatic setting.
- To assess the effects of chemotherapy regimens adapted to specific sarcoma histologies.
This is a protocol.